Aurobindo Pharma Ltd.
|
Nine Months RESULTS
|
|
You can view the
Nine Months Results
for the last 5 years.
Market Cap. (Rs.)
|
64652.47 Cr.
|
P/BV
|
2.41
|
Book Value (Rs.)
|
458.07
|
52 Week High/Low (Rs.)
|
1177/581
|
FV/ML
|
1/1
|
P/E(X)
|
33.54
|
Bookclosure
|
20/02/2024
|
EPS (Rs.)
|
32.90
|
Div Yield (%)
|
0.27
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 21212.58 | 18238.46 | 17571.21 | 18566.27 | 16674.55 |
Other Operating Income | 209.14 | 143.96 | 74.91 | 206.86 | 265.52 |
Total Income From Operations | 21421.72 | 18382.42 | 17646.12 | 18773.13 | 16940.07 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 8141.26 | 6981.94 | 5467.41 | 6327.13 | 5687.00 |
Purchase of Traded Goods | 1986.98 | 1461.68 | 1468.69 | 1823.17 | 1598.87 |
Increase/Decrease in Stocks | -586.22 | -81.33 | 679.98 | -654.91 | -54.01 |
Employees Cost | 2896.62 | 2670.35 | 2597.69 | 2680.62 | 2354.85 |
Depreciation | 1167.33 | 899.01 | 872.95 | 789.38 | 734.30 |
Other Expenses | 4827.17 | 4655.97 | 4019.98 | 4538.38 | 3844.98 |
Total Expenses | 18433.14 | 16587.62 | 15106.70 | 15503.77 | 14165.99 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 2988.58 | 1794.80 | 2539.42 | 3269.36 | 2774.08 |
Other Income | 436.04 | 178.33 | 271.47 | 302.74 | 53.61 |
P/L Before Interest, Excpt. Items & Tax | 3424.62 | 1973.13 | 2810.89 | 3572.10 | 2827.69 |
Interest | 200.28 | 84.88 | 39.43 | 56.27 | 127.94 |
P/L Before Exceptional Items & Tax | 3224.34 | 1888.25 | 2771.46 | 3515.83 | 2699.75 |
Exceptional Items | -69.75 | 0.00 | 34.79 | 2813.89 | -38.38 |
P/L Before Tax | 3154.59 | 1888.25 | 2806.25 | 6329.72 | 2661.37 |
Tax | 888.47 | 460.70 | 708.14 | 1750.08 | 684.99 |
P/L After Tax from Ordinary Activities | 2266.12 | 1427.55 | 2098.11 | 4579.64 | 1976.38 |
Net Profit/Loss For the Period | 2266.12 | 1427.55 | 2098.11 | 4579.64 | 1976.38 |
Share Of P/L Of Associates | -4.50 | -5.81 | -27.14 | -46.99 | 4.14 |
Net P/L After Minority Interest & Share Of Associates | 2261.62 | 1421.74 | 2070.97 | 4532.65 | 1980.52 |
| | | | | |
Equity Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 38.60 | 24.26 | 35.36 | 77.37 | 33.81 |
Diluted EPS (Rs.) | 38.60 | 24.26 | 35.36 | 77.37 | 33.81 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 38.60 | 24.26 | 35.36 | 77.37 | 33.81 |
Diluted EPS (Rs.) | 38.60 | 24.26 | 35.36 | 77.37 | 33.81 |
| | | | | |
PBITOE Margin (%) | 13.95 | 9.76 | 14.39 | 17.41 | 16.37 |
PBTE Margin (%) | 15.05 | 10.27 | 15.70 | 18.72 | 15.93 |
PBT Margin (%) | 14.72 | 10.27 | 15.90 | 33.71 | 15.71 |
PAT Margin (%) | 10.57 | 7.76 | 11.88 | 24.39 | 11.66 |
PAT After MI And SOA Margin (%) | 10.55 | 7.73 | 11.73 | 24.14 | 11.69 |